Immune evasion of tumor cells using membrane-bound complement regulatory proteins
- PMID: 10562709
- DOI: 10.1016/s0167-5699(99)01537-6
Immune evasion of tumor cells using membrane-bound complement regulatory proteins
Abstract
Membrane-bound complement regulatory proteins (mCRPs) play an important role in the protection of cells from complement-mediated injury. It is now apparent that malignant tumor cells also express these proteins to escape complement attack. Here, Arko Gorter and Seppo Meri discuss the implications of complement resistance for the immunotherapeutic treatment of solid tumors with monoclonal antibodies.
Similar articles
-
Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors.Mol Immunol. 2003 Sep;40(2-4):109-23. doi: 10.1016/s0161-5890(03)00112-3. Mol Immunol. 2003. PMID: 12914817 Review.
-
Membrane-associated proteins regulating the complement system: functions and deficiencies.Int Rev Immunol. 1993;10(1):87-101. doi: 10.3109/08830189309051173. Int Rev Immunol. 1993. PMID: 7688019 Review. No abstract available.
-
The Role of Membrane Bound Complement Regulatory Proteins in Tumor Development and Cancer Immunotherapy.Front Immunol. 2019 May 21;10:1074. doi: 10.3389/fimmu.2019.01074. eCollection 2019. Front Immunol. 2019. PMID: 31164885 Free PMC article. Review.
-
Complement function in mAb-mediated cancer immunotherapy.Trends Immunol. 2004 Mar;25(3):158-64. doi: 10.1016/j.it.2004.01.008. Trends Immunol. 2004. PMID: 15036044 Review. No abstract available.
-
Expression of complement inhibitors CD46, CD55, and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma.Blood. 2001 Sep 1;98(5):1352-7. doi: 10.1182/blood.v98.5.1352. Blood. 2001. PMID: 11520782
Cited by
-
The tumour microenvironment links complement system dysregulation and hypoxic signalling.Br J Radiol. 2019 Jan;92(1093):20180069. doi: 10.1259/bjr.20180069. Epub 2018 May 15. Br J Radiol. 2019. PMID: 29544344 Free PMC article. Review.
-
Plasma proteome changes associated with refractory cytopenia with multilineage dysplasia.Proteome Sci. 2011 Oct 5;9:64. doi: 10.1186/1477-5956-9-64. Proteome Sci. 2011. PMID: 21975265 Free PMC article.
-
Effect of membrane-bound complement regulatory proteins on tumor cell sensitivity to complement-dependent cytolysis triggered by heterologous expression of the α-gal xenoantigen.Oncol Lett. 2018 Jun;15(6):9061-9068. doi: 10.3892/ol.2018.8478. Epub 2018 Apr 12. Oncol Lett. 2018. PMID: 29805637 Free PMC article.
-
Targeted delivery of siRNA using transferrin-coupled lipoplexes specifically sensitizes CD71 high expressing malignant cells to antibody-mediated complement attack.Target Oncol. 2015 Sep;10(3):405-13. doi: 10.1007/s11523-014-0345-6. Epub 2014 Nov 15. Target Oncol. 2015. PMID: 25395366
-
Mechanisms of action of CD20 antibodies.Am J Cancer Res. 2012;2(6):676-90. Epub 2012 Nov 20. Am J Cancer Res. 2012. PMID: 23226614 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases